Osiris Therapeutics Appoints New Chief Financial Officer and Chief Business Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
Go back to Osiris Therapeutics Appoints New Chief Financial Officer and Chief Business Officer
September 17, 2015 8:02 AM EDT
Osiris Therapeutics (NASDAQ: OSIR) declared a special dividend of $0.20 per share.
The dividend will be payable on October 30, 2015, to stockholders of record on October 16, 2015.
The annual yield on the dividend is 1 percent.
"We are confident in the financial strength... More
September 17, 2015 8:02 AM EDT
Osiris Therapeutics (NASDAQ: OSIR) announced the appointment of Gregory Law, to serve as Chief Financial Officer and Dwayne Montgomery, to serve as Chief Business Officer.
Mr. Law has been employed with Osiris since 2014 as the Vice President of Finance and Principal Accounting Officer. Mr. Law has more than 25 years of finance and accounting experience in a variety of industries, including biotechnology, telecommunications, energy, private equity and consulting. Prior to joining Osiris in 2014, Mr. Law spent over a decade providing consulting services to public and private companies in the areas of interim CFO and controllership,... More
